PhRMA pres warns against DTC moratorium

Share this article:
In a statement warning the Senate against imposing a moratorium on DTC, PhRMA president and CEO Billy Tauzin said: “DTC empowers patients by increasing their awareness of diseases and available treatments. Banning this information— even for just a couple of years—is not in the best interest of patients and physicians who every day make important healthcare decisions.”

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.